Who is AstraZeneca plc?

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Should you buy AstraZeneca (AZN) stock?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AZN shares. View AZN analyst ratings or view top-rated stocks.

Is AstraZeneca plc a good stock to buy?

In addition, AstraZeneca PLC has a VGM Score of C (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading style). Valuation metrics show that AstraZeneca PLC may be undervalued. Its Value Score of B indicates it would be a good pick for value investors.